BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23726578)

  • 1. Superiority of AbCross enzyme-linked immunosorbent assay cross-match over the B-cell complement-dependent lymphocytotoxicity cross-match.
    Gombos P; Opelz G; Scherer S; Morath C; Zeier M; Schemmer P; Langer RM; Süsal C
    Transplant Proc; 2013 May; 45(4):1383-5. PubMed ID: 23726578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
    Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
    Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
    Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of donor-specific anti-human leukocyte antigen antibodies after the transplantation of a fully matched kidney allograft and its impact on the selection of a subsequent renal regraft: a case report.
    Schlaf G; Radam C; Wahle A; Altermann WW
    Transplant Proc; 2012 Jun; 44(5):1442-5. PubMed ID: 22664032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants.
    Kim Y; Yang CW; Moon IS; Kim M; Lim J; Park YJ; Han K; Oh EJ
    Ann Clin Lab Sci; 2010; 40(4):330-5. PubMed ID: 20947806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients.
    Kreijveld E; Hilbrands LB; van Berkel Y; Joosten I; Allebes W
    Transplantation; 2007 Nov; 84(9):1092-6. PubMed ID: 17998862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
    Süsal C; Opelz G
    Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HLA class I antibody screening and typing in the sera of dialyzed patients with CDC and ELISA techniques: association with graft survival].
    Kozma L; Bohaty I
    Orv Hetil; 2007 Mar; 148(12):553-8. PubMed ID: 17444021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
    Süsal C; Döhler B; Opelz G
    Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of donor-specific-antibodies by solid phase assay and its relevance to complement-dependent-lymphocytotoxicity cross-matching in kidney transplantation.
    Ho EK; Vasilescu ER; Vlad G; Clynes RA; Ratner LE; Suciu-Foca N
    Hum Immunol; 2014 Jun; 75(6):520-3. PubMed ID: 24662417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays.
    Gloor JM; Moore SB; Schneider BA; Degoey SR; Stegall MD
    Transplantation; 2007 Jul; 84(2):258-64. PubMed ID: 17667819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance.
    Schönemann C; Groth J; Leverenz S; May G
    Transplantation; 1998 Jun; 65(11):1519-23. PubMed ID: 9645818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
    Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Beltran Catalan S; Avila Bernabeu A; Crespo Albiach J; Montoro JA; Pallardo Mateu LM
    Transplant Proc; 2012 Nov; 44(9):2529-31. PubMed ID: 23146444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-HLA antibodies in nephropathic patients].
    Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
    G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools.
    Eng HS; Bennett G; Bardy P; Coghlan P; Russ GR; Coates PT
    Hum Immunol; 2009 Aug; 70(8):595-9. PubMed ID: 19527759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.
    Praticò-Barbato L; Conca R; Magistroni P; Leonardi G; Oda A; Rosati F; Leone E; Tacconella M; Roggero S; Segoloni GP; Amoroso A
    Transpl Immunol; 2008 Jul; 19(3-4):238-43. PubMed ID: 18675725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.